BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.4.8//EN BEGIN:VEVENT UID:988@biocityturku.fi DTSTART;TZID=Europe/Helsinki:20261103T140000 DTEND;TZID=Europe/Helsinki:20261103T150000 DTSTAMP:20261030T121147Z URL:https://biocityturku.fi/events/immunology-seminar-12/ SUMMARY:Immunology Seminar DESCRIPTION:November 3rd at 14:00-15:00\nOnline event\nin Zoom\nFlyer\n\nVi jay Kuchroo\, Director\, The Gene Lay Institute of Institute of Immunology and Inflammation\nBriahm and Women’s Hospital and Harvard Medical Schoo l\, Boston\nRole of TIM-3 in regulating stem-like T cells and anti-tumor i mmunity\n\nHost: Riitta Lahesmaa (rilahes@utu.fi)\n\nLink to seminar: http s://utu.zoom.us/j/62229630803\n\n \;\n\nRegister for the Immunology Se minar Series email list to get calendar invitation to the online seminar: https://link.webropolsurveys.com/S/D29C32AA6E8A2F7A\n\nImmunology seminar series is jointly organised by the Finnish Society for Immunology\, InFLAM ES Flagship and Turku Bioscience. For further information contact Anne Lah denperä  (ankahy@utu.fi) or Riitta Lahesmaa (rilahes@utu.fi)\, Universit y of Turku.\n\n \;\n\nDr. Vijay Kuchroo is the Samuel L. Wasserstrom P rofessor of Neurology at Harvard Medical School and Senior Scientist at Br igham and Women’s Hospital. Vijay Kuchroo is also an Institute member of the Broad Institute of Harvard and MIT\, a senior investigator at Klarman Cell Observatory project and Food Allergy Scientific Initiative (FASI) pr oject. He is the founding Director of the Gene Lay Institute of Immunology and Inflammation at Harvard Medical School\, Brigham and Women’s Hospit al and Mass General Hospital\, Boston.\n\nHis major research interests inc lude autoimmune diseases - particularly the role of co-stimulation - the g enetic basis of experimental autoimmune encephalomyelitis and multiple scl erosis\, and cell surface molecules and regulatory factors that regulate i nduction of T cell tolerance and dysfunction. His laboratory has made seve ral transgenic mice that serve as animal models for human multiple scleros is. His laboratory also first described TIM family of genes and identified Tim-3 as an inhibitory receptor expressed on T cells\, which is now being exploited for cancer immunotherapy. He was first to describe the developm ent of a highly pathogenic Th17 cells which has been shown to induce multi ple different autoimmune diseases in humans. A paper describing developmen t of Th17 authored by Dr. Kuchroo has been one of the highest cited papers in Immunology. More recently\, we have begun to study the impact of neuro immune interactions at the barrier surfaces in the induction and regulatio n of tissue inflammation.\n\nLink to Dr. Kuchroo's publications ATTACH;FMTTYPE=image/jpeg:https://biocityturku.fi/wp-content/uploads/Vijay K-ISS-Thumbnail@300x.png CATEGORIES:Other events END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:STANDARD DTSTART:20261025T030000 TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET END:STANDARD END:VTIMEZONE END:VCALENDAR